B
BioBoss
David Baram: Founder and CEO of EmendoBio
Episode 66
0:00-36:03
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
Publisher
BioBoss
Link
www.wyantsimboli.com/bioboss/david-baram-founder-and-ceo-of-emendobio/
Published
December 16, 2023
Duration
36 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
John Simboli
B
BioBoss
@bioboss
#davidbaram #founder #emendobio #lifesciences #investing
